Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The risk COVID-19 presents to MDS patients

Valeria Santini, MD, University of Florence, Florence, Italy, outlines the clinical impact of the COVID-19 outbreak in Italy, how myelodysplastic syndrome (MDS) patients are being implicated and the measures being taken to mitigate the negative consequences of this pandemic. This interview was filmed during an online conference call with VJHemOnc on the 17th of March 2020.